Xtrackers MSCI Global SDG 3 Good Health

Global companies

(SDG3)
£26.39
Previous business day’s close price
+£1.32 (+5.26%)
max available period
£23.15
£28.38

13 Feb 23
20 Nov 24

Details

ETF description

This ETF is designed to invest in companies that contribute to good health and well‑being, aligning with the United Nations' Sustainable Development Goals. It focuses on businesses involved in sectors such as healthcare, pharmaceuticals, biotechnology, and medical devices. By investing in this ETF, individuals gain exposure to a diverse range of companies that are working towards improving health outcomes and advancing medical innovation globally.

Investors who are passionate about health‑related initiatives and the positive impact of healthcare advancements may find this ETF appealing. It may attract those who wish to support companies that prioritize public health while potentially benefiting from the growth in the healthcare sector. The ETF aims to offer a balanced representation of various industries related to health, which helps to manage investment risk.

Issuer details

Xtrackers is a large and established provider of high quality ETFs and exchange traded commodities (ETCs). It is the ETF and ETC segment of the German asset manager DWS.

Xtrackers ETFs are listed on eleven stock exchanges globally and have over £169.53bn (as at June 2024) in assets under management, making Xtrackers one of the largest providers of ETFs and ETCs by AUM.

Index details

The MSCI ACWI IMI SDG 3 Good Health and Well‑being Select Index aims to reflect the performance of large, medium, and small‑capitalisation companies across developed and emerging markets globally; companies associated with a positive contribution to Sustainable Development Goal 3: ensure healthy lives and promote well‑being for all at all ages of the United Nations 2030 Agenda for Sustainable Development and which meet certain ESG criteria. To be eligible for inclusion securities must meet a certain threshold on the theme of digital healthcare and/or be part of the certain business segments including not limited to: (i) major disease treatment; (ii) sanitation; (iii) conventional pollution control solutions; and (iv) low toxicity and/or low volatile organic compounds solutions. The index is reviewed semi‑annually and rebalanced at least quarterly.

This ETF is in collections:

ETF Breakdown

Abbott Laboratories
5.0%
Vertex Pharmaceuticals, Inc.
4.9%
Stryker Corp.
4.7%
Bristol‑Myers Squibb Co.
4.4%
Thermo Fisher
4.2%
Novartis AG
4.2%
Abbvie Inc
4.2%
AMGEN Inc.
4.1%
Danaher Corp.
4.1%
Lilly
4.1%
Gilead Sciences, Inc.
3.7%
Novo Nordisk As Class B
3.6%
Astrazeneca plc
3.6%
Boston Scientific Corp.
3.5%
Merck & Co Inc
3.4%
Regeneron Pharmaceuticals, Inc.
2.5%
CSL Ltd.
2.3%
Medtronic Plc
2.3%
GSK Plc
1.8%
Kimberly‑Clark Corp.
1.4%
Agilent Technologies Inc.
1.4%
Edwards Lifesciences Corp
1.3%
Ge Healthcare Technologies Inc
1.3%
argenx SE
1.3%
Daiichi Sankyo Co., Ltd.
1.2%
Resmed Inc.
1.1%
Dexcom Inc
1.1%
Alnylam Pharmaceuticals Inc
1.0%
Cooper Inc
0.7%
Insulet Corporation
0.7%
United Therapeutics Corp
0.7%
Chugai Ro Co Ltd
0.6%
Incyte Corp.
0.6%
Hologic, Inc.
0.5%
Biomarin Pharmaceutical Inc.
0.5%
Essity AB (publ)
0.5%
Genmab
0.4%
Siemens Healthineers AG
0.4%
Insmed Inc
0.4%
BeiGene Ltd
0.4%
Bio‑Techne Corp
0.3%
Qiagen N.V.
0.3%
Baxter International Inc.
0.3%
Sarepta Therapeutics Inc
0.3%
Unicharm
0.3%
Teleflex Incorporated
0.3%
Jazz Pharmaceuticals plc
0.3%
Exelixis Inc
0.3%
Bio‑Rad Laboratories Inc.
0.2%
Shionogi & Co. Ltd.
0.2%
Sysmex Corporation
0.2%
Swedish Orphan Biovitrum AB
0.2%
Akeso Inc
0.2%
Roche Holding AG
0.2%
Innovent Biologics Inc
0.2%
Eisai Co Ltd
0.2%
Merit Medical Systems, Inc.
0.2%
Penumbra Inc
0.2%
Lantheus Holdings Inc
0.1%
ICU Medical, Inc.
0.1%
Ono Pharmaceutical Co. Ltd
0.1%
Axsome Therapeutics Inc
0.1%
Kyowa Kirin Co. Ltd.
0.1%
iRhythm Technologies Inc
0.1%
Inari Medical Inc
0.1%
Organon & Co.
< 0.1%
Agios Pharmaceuticals Inc
< 0.1%
Ipsen
< 0.1%
Catalyst Pharmaceuticals Inc
< 0.1%
PTC Therapeutics Inc
< 0.1%
Johnson Matthey plc
< 0.1%
Amicus Therapeutics Inc
< 0.1%
Asahi Intecc Co. Ltd.
< 0.1%
Toto Ltd
< 0.1%
Jiangsu Hansoh Pharmaceutical Group Co Ltd
< 0.1%
Tandem Diabetes Care Inc
< 0.1%
Diasorin S.p.A.
< 0.1%
Veracyte Inc
< 0.1%
Atricure Inc
< 0.1%
Zai Lab Limited
< 0.1%
Conmed Corp (Pre‑Merger)
< 0.1%
Hengan International Group Co. Ltd.
< 0.1%
Dynavax Technologies Corp.
< 0.1%
Kimberly‑Clark de Mexico SAB de CV
< 0.1%
H. Lundbeck AS
< 0.1%
Neogenomics Inc.
< 0.1%
Lemaitre Vascular Inc
< 0.1%
Supernus Pharmaceuticals Inc
< 0.1%
QuidelOrtho Corporation
< 0.1%
LivaNova PLC
< 0.1%
Teladoc Health Inc
< 0.1%
Integra Lifesciences Holdings Corp
< 0.1%
Biocryst Pharmaceuticals Inc.
< 0.1%
3SBIO Inc
< 0.1%
Elekta AB (publ)
< 0.1%
Indivior Plc
< 0.1%
Mannkind Corp
< 0.1%
Harmony Biosciences Holdings Inc
< 0.1%
Innoviva Inc
< 0.1%
Artivion Inc
< 0.1%
Kiniksa Pharmaceuticals Internatio
< 0.1%
Laboratorios Farmaceuticos Rovi S.A.
< 0.1%
Embecta Corp
< 0.1%
Nipro Corp
< 0.1%
China Medical System Hldgs Ltd
< 0.1%
Oneness Biotech Co Ltd
< 0.1%
Polynovo Limited
< 0.1%
Shandong Weigao Group Medical Polymer Co. Ltd.
< 0.1%
Avanos Medical Inc
< 0.1%
Ping An Healthcare And Technology Company Limited
< 0.1%
Chongqing Zhifei Biological Products Company
< 0.1%
Pharming Group N.V.
< 0.1%
Ontex Group NV
< 0.1%
Venus Medtech (Hangzhou) Inc.
< 0.1%
Others
0%
£26.39
Previous business day’s close price

Capital at risk

Why InvestEngine

Unbeatable value

From commission‑free investing, to zero‑ISA fees, we’re proud of our low fees.
Here's how we're able to do it

Choice of 700+ ETFs

Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
Browse investments

Actionable insights

Know exactly which companies, sectors and regions are in your portfolio.

Powerful automation

Grow your wealth the easy way with automated investing features

Easy diversification

Fractional investing lets you put as little as £1 in any ETF.

DIY or Managed

Build and manage your own portfolio or leave it to us.

ETFs have spreads and annual charges and come with risks like market volatility, liquidity, and concentration, and may not always accurately track their index. Past performance and forecasts are not reliable indicators of future results. The value of your investments, including any income, can rise or fall. You may get back less than you originally invested.
Whenever you invest, your capital is at risk
This could mean the value of your investments goes down as well as up.
Understand more about investment risk.
© InvestEngine Limited 2024. All rights reserved.